CNBC·3 min read·medium
What it means for patients, drugmakers and prices
E
Elsa Ohlen
✦AI Summary
President Trump has proposed significant tariffs on imported generic medicines to encourage domestic manufacturing. The generic drug industry warns that structural challenges, such as reimbursement issues, may hinder this transition despite the proposed timeline.
President Donald Trump 's proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can shift production to the U.S. before duties of as much as 200% take effect.
politicsbusinesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in